Thursday - September 24, 2026
Goodwin Advises BoomRay on Intellectual Property Aspects for License Agreement for Up To $900 Million With Novartis
September 24, 2026
BOSTON, Massachusetts, Sept. 24 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises BoomRay on Intellectual Property Aspects for License Agreement for Up To $900 Million With Novartis

*

The Life Sciences team advised BoomRay Pharmaceuticals ("BoomRay") on IP aspects associated with entering into an exclusive global license agreement with Novartis Pharma AG ("Novartis") fo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products